Multicenter trial in North America of urolume urinary sphincter prosthesis

M. B. Chancellor, D. A. Rivas, T. Linsenmeyer, C. A. Abdill, C. F D Ackman, R. A. Appell, J. Bennett, J. Binard, T. B. Boone, M. P. Chetner, A. Defalco, J. Foote, J. Gajewski, B. Green, S. Juma, R. MacMillan, M. Mayo, C. G. Roehrborn, Anthony R Stone

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

We investigated the effectiveness and associated complications of treatment with an endoluminal urethral sphincter prosthesis in 153 spinal cord injury men (mean age 36 years, range 16 to 74 years) with urodynamically diagnosed detrusor-external sphincter dyssynergia. These patients were prospectively treated with a urethral sphincter stent at 15 centers in North America. Followup ranged from 2 to 33 months. Voiding pressures averaged 76 ± 28, 42 ± 21, 44 ± 38, 35 ± 18 and 32 ± 20 cm. water, respectively, before prosthesis insertion in 153 patients, and at 3 months in 123, 6 months in 114, 12 months in 98 and 24 months in 22. A significant decrease in voiding pressure was noted in the 22 patients at 24 months compared with matched preoperative data (80 ± 25 cm. water, p = 0.03). The residual urine decreased from 181 ± 154 ml. before insertion to 82 ± 93 ml. at 24 months (p = 0.01). Maximum cystometric capacity remained constant, with a mean of 195 ± 158 ml. before insertion to 248 ± 122 ml. at 24 months (p = 0.17). No significant differences were apparent after 24 months of followup in any of the urodynamic parameters between 44 patients with and 109 without previous external sphincterotomy. Hemorrhage requiring blood transfusion, obstructive hyperplastic epithelial overgrowth and soft tissue erosion did not occur. No deleterious effects were observed on renal or erectile function. Of the patients 43 (28.1%) required 2 prostheses to bridge the external sphincter completely. Stent removal was required in 10 patients. Seven explanations were required for prosthesis migration, 1 for pain and urethral edema, 1 for inability to maintain a condom catheter, and 1 for nonepithelialization and secondary bladder neck obstruction. A total of 13 patients (8.5%) required a subsequent operation for bladder neck obstruction. Therefore, the sphincter prosthesis is an attractive modality for the treatment of external sphincter dyssynergia in patients with and without previous external sphincterotomy because of its ease of deployment and minimal associated morbidity.

Original languageEnglish (US)
Pages (from-to)924-930
Number of pages7
JournalJournal of Urology
Volume152
Issue number3
StatePublished - 1994
Externally publishedYes

Fingerprint

North America
Multicenter Studies
Prostheses and Implants
Urinary Bladder Neck Obstruction
Urethra
Ataxia
Stents
Prosthesis Failure
Pressure
Water
Urodynamics
Condoms
Spinal Cord Injuries
Blood Transfusion
Edema
Catheters
Urine
Hemorrhage
Morbidity
Kidney

Keywords

  • prosthesis
  • spinal cord injuries
  • urethra
  • urinary tract infections
  • urodynamics

ASJC Scopus subject areas

  • Urology

Cite this

Chancellor, M. B., Rivas, D. A., Linsenmeyer, T., Abdill, C. A., Ackman, C. F. D., Appell, R. A., ... Stone, A. R. (1994). Multicenter trial in North America of urolume urinary sphincter prosthesis. Journal of Urology, 152(3), 924-930.

Multicenter trial in North America of urolume urinary sphincter prosthesis. / Chancellor, M. B.; Rivas, D. A.; Linsenmeyer, T.; Abdill, C. A.; Ackman, C. F D; Appell, R. A.; Bennett, J.; Binard, J.; Boone, T. B.; Chetner, M. P.; Defalco, A.; Foote, J.; Gajewski, J.; Green, B.; Juma, S.; MacMillan, R.; Mayo, M.; Roehrborn, C. G.; Stone, Anthony R.

In: Journal of Urology, Vol. 152, No. 3, 1994, p. 924-930.

Research output: Contribution to journalArticle

Chancellor, MB, Rivas, DA, Linsenmeyer, T, Abdill, CA, Ackman, CFD, Appell, RA, Bennett, J, Binard, J, Boone, TB, Chetner, MP, Defalco, A, Foote, J, Gajewski, J, Green, B, Juma, S, MacMillan, R, Mayo, M, Roehrborn, CG & Stone, AR 1994, 'Multicenter trial in North America of urolume urinary sphincter prosthesis', Journal of Urology, vol. 152, no. 3, pp. 924-930.
Chancellor MB, Rivas DA, Linsenmeyer T, Abdill CA, Ackman CFD, Appell RA et al. Multicenter trial in North America of urolume urinary sphincter prosthesis. Journal of Urology. 1994;152(3):924-930.
Chancellor, M. B. ; Rivas, D. A. ; Linsenmeyer, T. ; Abdill, C. A. ; Ackman, C. F D ; Appell, R. A. ; Bennett, J. ; Binard, J. ; Boone, T. B. ; Chetner, M. P. ; Defalco, A. ; Foote, J. ; Gajewski, J. ; Green, B. ; Juma, S. ; MacMillan, R. ; Mayo, M. ; Roehrborn, C. G. ; Stone, Anthony R. / Multicenter trial in North America of urolume urinary sphincter prosthesis. In: Journal of Urology. 1994 ; Vol. 152, No. 3. pp. 924-930.
@article{7888be5f008e408fbdbe578e12e665f6,
title = "Multicenter trial in North America of urolume urinary sphincter prosthesis",
abstract = "We investigated the effectiveness and associated complications of treatment with an endoluminal urethral sphincter prosthesis in 153 spinal cord injury men (mean age 36 years, range 16 to 74 years) with urodynamically diagnosed detrusor-external sphincter dyssynergia. These patients were prospectively treated with a urethral sphincter stent at 15 centers in North America. Followup ranged from 2 to 33 months. Voiding pressures averaged 76 ± 28, 42 ± 21, 44 ± 38, 35 ± 18 and 32 ± 20 cm. water, respectively, before prosthesis insertion in 153 patients, and at 3 months in 123, 6 months in 114, 12 months in 98 and 24 months in 22. A significant decrease in voiding pressure was noted in the 22 patients at 24 months compared with matched preoperative data (80 ± 25 cm. water, p = 0.03). The residual urine decreased from 181 ± 154 ml. before insertion to 82 ± 93 ml. at 24 months (p = 0.01). Maximum cystometric capacity remained constant, with a mean of 195 ± 158 ml. before insertion to 248 ± 122 ml. at 24 months (p = 0.17). No significant differences were apparent after 24 months of followup in any of the urodynamic parameters between 44 patients with and 109 without previous external sphincterotomy. Hemorrhage requiring blood transfusion, obstructive hyperplastic epithelial overgrowth and soft tissue erosion did not occur. No deleterious effects were observed on renal or erectile function. Of the patients 43 (28.1{\%}) required 2 prostheses to bridge the external sphincter completely. Stent removal was required in 10 patients. Seven explanations were required for prosthesis migration, 1 for pain and urethral edema, 1 for inability to maintain a condom catheter, and 1 for nonepithelialization and secondary bladder neck obstruction. A total of 13 patients (8.5{\%}) required a subsequent operation for bladder neck obstruction. Therefore, the sphincter prosthesis is an attractive modality for the treatment of external sphincter dyssynergia in patients with and without previous external sphincterotomy because of its ease of deployment and minimal associated morbidity.",
keywords = "prosthesis, spinal cord injuries, urethra, urinary tract infections, urodynamics",
author = "Chancellor, {M. B.} and Rivas, {D. A.} and T. Linsenmeyer and Abdill, {C. A.} and Ackman, {C. F D} and Appell, {R. A.} and J. Bennett and J. Binard and Boone, {T. B.} and Chetner, {M. P.} and A. Defalco and J. Foote and J. Gajewski and B. Green and S. Juma and R. MacMillan and M. Mayo and Roehrborn, {C. G.} and Stone, {Anthony R}",
year = "1994",
language = "English (US)",
volume = "152",
pages = "924--930",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Multicenter trial in North America of urolume urinary sphincter prosthesis

AU - Chancellor, M. B.

AU - Rivas, D. A.

AU - Linsenmeyer, T.

AU - Abdill, C. A.

AU - Ackman, C. F D

AU - Appell, R. A.

AU - Bennett, J.

AU - Binard, J.

AU - Boone, T. B.

AU - Chetner, M. P.

AU - Defalco, A.

AU - Foote, J.

AU - Gajewski, J.

AU - Green, B.

AU - Juma, S.

AU - MacMillan, R.

AU - Mayo, M.

AU - Roehrborn, C. G.

AU - Stone, Anthony R

PY - 1994

Y1 - 1994

N2 - We investigated the effectiveness and associated complications of treatment with an endoluminal urethral sphincter prosthesis in 153 spinal cord injury men (mean age 36 years, range 16 to 74 years) with urodynamically diagnosed detrusor-external sphincter dyssynergia. These patients were prospectively treated with a urethral sphincter stent at 15 centers in North America. Followup ranged from 2 to 33 months. Voiding pressures averaged 76 ± 28, 42 ± 21, 44 ± 38, 35 ± 18 and 32 ± 20 cm. water, respectively, before prosthesis insertion in 153 patients, and at 3 months in 123, 6 months in 114, 12 months in 98 and 24 months in 22. A significant decrease in voiding pressure was noted in the 22 patients at 24 months compared with matched preoperative data (80 ± 25 cm. water, p = 0.03). The residual urine decreased from 181 ± 154 ml. before insertion to 82 ± 93 ml. at 24 months (p = 0.01). Maximum cystometric capacity remained constant, with a mean of 195 ± 158 ml. before insertion to 248 ± 122 ml. at 24 months (p = 0.17). No significant differences were apparent after 24 months of followup in any of the urodynamic parameters between 44 patients with and 109 without previous external sphincterotomy. Hemorrhage requiring blood transfusion, obstructive hyperplastic epithelial overgrowth and soft tissue erosion did not occur. No deleterious effects were observed on renal or erectile function. Of the patients 43 (28.1%) required 2 prostheses to bridge the external sphincter completely. Stent removal was required in 10 patients. Seven explanations were required for prosthesis migration, 1 for pain and urethral edema, 1 for inability to maintain a condom catheter, and 1 for nonepithelialization and secondary bladder neck obstruction. A total of 13 patients (8.5%) required a subsequent operation for bladder neck obstruction. Therefore, the sphincter prosthesis is an attractive modality for the treatment of external sphincter dyssynergia in patients with and without previous external sphincterotomy because of its ease of deployment and minimal associated morbidity.

AB - We investigated the effectiveness and associated complications of treatment with an endoluminal urethral sphincter prosthesis in 153 spinal cord injury men (mean age 36 years, range 16 to 74 years) with urodynamically diagnosed detrusor-external sphincter dyssynergia. These patients were prospectively treated with a urethral sphincter stent at 15 centers in North America. Followup ranged from 2 to 33 months. Voiding pressures averaged 76 ± 28, 42 ± 21, 44 ± 38, 35 ± 18 and 32 ± 20 cm. water, respectively, before prosthesis insertion in 153 patients, and at 3 months in 123, 6 months in 114, 12 months in 98 and 24 months in 22. A significant decrease in voiding pressure was noted in the 22 patients at 24 months compared with matched preoperative data (80 ± 25 cm. water, p = 0.03). The residual urine decreased from 181 ± 154 ml. before insertion to 82 ± 93 ml. at 24 months (p = 0.01). Maximum cystometric capacity remained constant, with a mean of 195 ± 158 ml. before insertion to 248 ± 122 ml. at 24 months (p = 0.17). No significant differences were apparent after 24 months of followup in any of the urodynamic parameters between 44 patients with and 109 without previous external sphincterotomy. Hemorrhage requiring blood transfusion, obstructive hyperplastic epithelial overgrowth and soft tissue erosion did not occur. No deleterious effects were observed on renal or erectile function. Of the patients 43 (28.1%) required 2 prostheses to bridge the external sphincter completely. Stent removal was required in 10 patients. Seven explanations were required for prosthesis migration, 1 for pain and urethral edema, 1 for inability to maintain a condom catheter, and 1 for nonepithelialization and secondary bladder neck obstruction. A total of 13 patients (8.5%) required a subsequent operation for bladder neck obstruction. Therefore, the sphincter prosthesis is an attractive modality for the treatment of external sphincter dyssynergia in patients with and without previous external sphincterotomy because of its ease of deployment and minimal associated morbidity.

KW - prosthesis

KW - spinal cord injuries

KW - urethra

KW - urinary tract infections

KW - urodynamics

UR - http://www.scopus.com/inward/record.url?scp=0027932767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027932767&partnerID=8YFLogxK

M3 - Article

VL - 152

SP - 924

EP - 930

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3

ER -